Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiawei Jinshui Liujun Jian Decoction (FJLD) is a Traditional Chinese Medicine (TCM) herbal formulation primarily used for the treatment of chronic respiratory conditions. It is a modified version of the classical Jinshui Liujun Jian, enriched with additional herbs such as milkvetch root (Astragalus). The decoction typically comprises prepared Rehmannia root, Pinellia ternata rhizome, tangerine peel (chenpi), licorice, Poria cocos, and milkvetch root. Research indicates that FJLD exerts therapeutic effects through the modulation of the TNF-α/NF-κB signaling pathway, regulation of pulmonary water metabolism, and enhancement of immune function. It is frequently studied as a treatment for chronic obstructive pulmonary disease (COPD), asthma, and chronic bronchitis, and as an adjunctive therapy for non-small cell lung cancer (NSCLC) to improve patient quality of life and immune response.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jiawei jinshui liujun jian decoction.